Primary biliary cirrhosis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Removing from Primary care) |
|||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Effective measures for the secondary prevention of primary biliary cirrhosis include follow up with [[liver function tests]] , [[Thyroid function tests|thyroid status]] , [[Endoscopy|upper GI endoscopy]], [[bone mineral density]], [[Fat soluble vitamins|fat-soluble vitamin]] levels, [[ultrasound]] and [[alpha-fetoprotein]] levels to screen for [[hepatocellular carcinoma]] among aged men and patients with underlying [[cirrhosis]]. | Effective measures for the secondary prevention of primary biliary cirrhosis include follow up with [[liver function tests]], [[Thyroid function tests|thyroid status]], [[Endoscopy|upper GI endoscopy]], [[bone mineral density]], [[Fat soluble vitamins|fat-soluble vitamin]] levels, [[ultrasound]] and [[alpha-fetoprotein]] levels to screen for [[hepatocellular carcinoma]] among aged men and patients with underlying [[cirrhosis]]. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
*Effective measures for the secondary prevention of primary biliary cirrhosis include:<ref name="pmid16356577">{{cite journal |vauthors=Chazouillères O, Wendum D, Serfaty L, Rosmorduc O, Poupon R |title=Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome |journal=J. Hepatol. |volume=44 |issue=2 |pages=400–6 |year=2006 |pmid=16356577 |doi=10.1016/j.jhep.2005.10.017 |url=}}</ref><ref name="PouponChazouilleres2006">{{cite journal|last1=Poupon|first1=Raoul|last2=Chazouilleres|first2=Olivier|last3=Corpechot|first3=Christophe|last4=Chrétien|first4=Yves|title=Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis|journal=Hepatology|volume=44|issue=1|year=2006|pages=85–90|issn=0270-9139|doi=10.1002/hep.21229}}</ref><ref name=" | *Effective measures for the secondary prevention of primary biliary cirrhosis include:<ref name="pmid16356577">{{cite journal |vauthors=Chazouillères O, Wendum D, Serfaty L, Rosmorduc O, Poupon R |title=Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome |journal=J. Hepatol. |volume=44 |issue=2 |pages=400–6 |year=2006 |pmid=16356577 |doi=10.1016/j.jhep.2005.10.017 |url=}}</ref><ref name="PouponChazouilleres2006">{{cite journal|last1=Poupon|first1=Raoul|last2=Chazouilleres|first2=Olivier|last3=Corpechot|first3=Christophe|last4=Chrétien|first4=Yves|title=Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis|journal=Hepatology|volume=44|issue=1|year=2006|pages=85–90|issn=0270-9139|doi=10.1002/hep.21229}}</ref><ref name="pmid7958699">{{cite journal |vauthors=Colombato LA, Alvarez F, Côté J, Huet PM |title=Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis? |journal=Gastroenterology |volume=107 |issue=6 |pages=1839–43 |year=1994 |pmid=7958699 |doi= |url=}}</ref><ref name="pmid11232713">{{cite journal |vauthors=Weyman RL, Voigt M |title=Consecutive occurrence of primary biliary cirrhosis and autoimmune hepatitis: a case report and review of the literature |journal=Am. J. Gastroenterol. |volume=96 |issue=2 |pages=585–7 |year=2001 |pmid=11232713 |doi=10.1111/j.1572-0241.2001.03562.x |url=}}</ref> | ||
**Follow up with [[liver function tests]] every 3 to 6 months. | **Follow up with [[liver function tests]] every 3 to 6 months. | ||
**Follow up with [[Thyroid function tests|thyroid status]] annually. | **Follow up with [[Thyroid function tests|thyroid status]] annually. | ||
| Line 22: | Line 22: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Gastroenterology]] | |||
[[Category:Hepatology]] | |||
[[Category:Disease]] | |||
[[Category:Rheumatology]] | |||
[[Category:Medicine]] | |||
[[Category:Up-To-Date]] | |||
Latest revision as of 23:49, 29 July 2020
|
Primary Biliary Cirrhosis Microchapters |
|
Differentiating Primary Biliary Cirrhosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Primary biliary cirrhosis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Primary biliary cirrhosis secondary prevention |
|
Risk calculators and risk factors for Primary biliary cirrhosis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]
Overview
Effective measures for the secondary prevention of primary biliary cirrhosis include follow up with liver function tests, thyroid status, upper GI endoscopy, bone mineral density, fat-soluble vitamin levels, ultrasound and alpha-fetoprotein levels to screen for hepatocellular carcinoma among aged men and patients with underlying cirrhosis.
Secondary Prevention
- Effective measures for the secondary prevention of primary biliary cirrhosis include:[1][2][3][4]
- Follow up with liver function tests every 3 to 6 months.
- Follow up with thyroid status annually.
- Follow up with upper GI endoscopy to assess for development of varices every 2-3 years.
- Follow up with bone mineral density every 2-4 years, depending upon the baseline density and severity of cholestasis.
- Follow up with fat-soluble vitamin levels (Vitamin A,D&K) annually in patients with bilirubin >2mg/dl.
- Follow up with ultrasound and alpha-fetoprotein levels to screen for hepatocellular carcinoma every 6 to 12 months among aged men and patients with underlying cirrhosis.
References
- ↑ Chazouillères O, Wendum D, Serfaty L, Rosmorduc O, Poupon R (2006). "Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome". J. Hepatol. 44 (2): 400–6. doi:10.1016/j.jhep.2005.10.017. PMID 16356577.
- ↑ Poupon, Raoul; Chazouilleres, Olivier; Corpechot, Christophe; Chrétien, Yves (2006). "Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis". Hepatology. 44 (1): 85–90. doi:10.1002/hep.21229. ISSN 0270-9139.
- ↑ Colombato LA, Alvarez F, Côté J, Huet PM (1994). "Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?". Gastroenterology. 107 (6): 1839–43. PMID 7958699.
- ↑ Weyman RL, Voigt M (2001). "Consecutive occurrence of primary biliary cirrhosis and autoimmune hepatitis: a case report and review of the literature". Am. J. Gastroenterol. 96 (2): 585–7. doi:10.1111/j.1572-0241.2001.03562.x. PMID 11232713.